Indian Journal of Rheumatology

REVIEW ARTICLE
Year
: 2019  |  Volume : 14  |  Issue : 5  |  Page : 19--26

Drug-Induced Interstitial Lung Disease


Wei-I Lee1, Pravin Hissaria2 
1 Department of Clinical Immunology and Allergy, Royal Adelaide Hospita, Adelaide SA 5000, Australia
2 Department of Immunopathology, SA Pathology, Adelaide SA 5000, Australia

Correspondence Address:
Dr. Pravin Hissaria
Department of Immunopathology, SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia 5000
Australia

Drug-induced interstitial lung disease (DIILD) represents a rare but potentially fatal adverse drug reaction. A large number of drugs have been implicated to have this potential risk, including chemotherapeutics and disease-modifying antirheumatic drugs. The clinical presentations, laboratory investigations, pulmonary function test result, and imaging and histopathological findings associated with drug-induced pulmonary fibrosis are nonspecific. The diagnosis is achieved after the exclusion of alternative diagnosis, such as infection, pulmonary edema, and connective tissue diseases. However, sometimes, the underlying diseases (e.g., rheumatoid arthritis) and the drugs used to treat the disease (e.g., methotrexate) can both cause ILD; it is often difficult to tease out causality especially if baseline pulmonary assessment (respiratory function test and imaging) is incomplete prior to the commencement of the drug therapy. Many efforts have been put into investigating the pathogenesis of the DIILD, particularly as animal model of bleomycin-induced pulmonary fibrosis has been used as a surrogate for idiopathic pulmonary fibrosis. However, more research is required to improve our understanding of pathogenesis in order to develop more sensitive and specific diagnostic tests as well as to establish evidence-based treatment approach.


How to cite this article:
Lee WI, Hissaria P. Drug-Induced Interstitial Lung Disease.Indian J Rheumatol 2019;14:19-26


How to cite this URL:
Lee WI, Hissaria P. Drug-Induced Interstitial Lung Disease. Indian J Rheumatol [serial online] 2019 [cited 2020 Jan 22 ];14:19-26
Available from: http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=5;spage=19;epage=26;aulast=Lee;type=0